The role of CRKL in Breast Cancer Metastasis: Insights from Systems Biology

TL;DR

This study uses systems biology tools to investigate the role of CRKL in breast cancer metastasis, revealing its involvement in ERK1/2 signaling and regulation of LYN, which may inform future therapeutic strategies.

Contribution

The paper demonstrates the involvement of CRKL in breast cancer metastasis through systems biology analysis, highlighting its regulatory role in ERK1/2 signaling and LYN regulation.

Findings

CRKL is involved in positive regulation of ERK1/2 pathway.

CRKL contributes to regulation of LYN via feed forward loop.

CRKL may be a potential target in breast cancer metastasis.

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression post-transcriptionally. They are involved in key biological processes and then may play a major role in the development of human diseases including cancer, in particular their involvement in breast cancer metastasis has been confirmed. Recently, the authors of ref.(\cite{key1} have found that miR-429 may have a role in the inhibition of breast cancer metastasis and have identified its target gene CRKL as a potential candidate. In this paper, by using systems biology tools we have shown that CRKL is involved in positive regulation of ERK1/2 signaling pathway and contribute to the regulation of LYN through a topological generalization of feed forward loop.